Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasNature 2022 Feb 07;[EPub Ahead of Print], RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, LM Schultz, RM Richards, L Jiang, V Barsan, R Mancusi, AC Geraghty, Z Good, AY Mochizuki, SM Gillespie, AMS Toland, J Mahdi, A Reschke, E Nie, IJ Chau, MC Rotiroti, CW Mount, C Baggott, S Mavroukakis, E Egeler, J Moon, C Erickson, S Green, M Kunicki, M Fujimoto, Z Ehlinger, W Reynolds, S Kurra, KE Warren, S Prabhu, H Vogel, L Rasmussen, TT Cornell, S Partap, PG Fisher, CJ Campen, MG Filbin, G Grant, B Sahaf, KL Davis, SA Feldman, CL Mackall, M Monje
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.